The Legend of the Year Cardiology & Cardiothoracic Surgery Dr. A.G.K. Gokhale Apollo HospitalsThe Legend of the Year Cardiology & Cardiothoracic Surgery Dr. P.C. Rath Apollo HospitalsThe Legend of the Year Cardiology & Cardiothoracic Surgery Dr. Sunil Kapoor Apollo HospitalsThe Legend of the Year Cardiology & Cardiothoracic Surgery Dr. Vijay Dixit Apollo HospitalsThe Legend of the Year ENT Dr. E.C. Vinaya Kumar Apollo HospitalsThe Rising Star General Medicine Dr. Rajiv Paul Apollo HospitalsThe Legend of the Year Neurology & Neurosurgery Dr. Alok Ranjan Apollo HospitalsThe Legend of the Year Obstetrics & Gynecology Dr. Rooma Sinha Apollo HospitalsThe Rising Star Oncology Dr. T.P.S Bhandari Apollo HospitalsThe Legend of the Year Oncology Dr. Vijay Anand Reddy Apollo HospitalsThe Legend of the Year Ophthalmology Dr. Rajesh Fogla Apollo HospitalsThe Legend of the Year Orthopedics Dr. Jairamchander Pingle Apollo HospitalsThe Legend of the Year Urology Dr. K. Subrahmanyam Apollo Hospitals   

Apollo Hospitals launched a super specialty hospital at Sheshadripuram in Bangalore. Present at the inaugural ceremony were Shri. Dinesh Gundurao, Hon’ble Minister of State for Food, Civil Supply and Consumer Affairs, Dr. Prathap C Reddy , Chairman & Founder, Apollo Hospitals, Ms. Suneeta Reddy, Managing Director, Apollo Hospitals, Gen. Dr. Naresh Parmar, CEO – Apollo Hospitals, Karnataka Region and Mr Ravindra Pai, COO, Apollo Hospitals, Sheshadripuram, amongst other dignitaries.The 200 bedded facility developed in 2 acres , is the fourth hospital in the state of Karnataka in addition to the ones existing at Bannerghatta Road & Jayanagar in Bangalore and in Mysore. Apollo Hospitals continues to keep up with its commitment towards bringing quality healthcare closer and accessible to all. “We started about 33 years back with our first hospital at Chennai and the journey so far has been remarkable. Apollo Hospitals has been established to address the rapid rise of NCDs that are affecting the population of Bangalore”, said Dr Prathap C Reddy, Chairman& Founder, Apollo Hospitals, “It is disheartening to see that people continue to suffer from disorders like Heart Attacks, Epilepsy, Stroke and many others diseases despite the fact that timely diagnosis and proper treatment can prevent or cure any disease”, he further added.Apollo Hospital, Sheshadripuram , is well-equipped with latest infrastructure, state of the art technology and a team of specialists to address and cater to the rising need of attention towards non communicable diseases which are on the rise in the state. “Particularly in Bangalore, we see about 1200 cases coming to us every month on an average between the age group of 30-40 years. The primary focus of the Apollo Hospital, Sheshadripuram , would be to tackle NCDs that have witnessed a rapid increase in the number of cases especially in the recent years”, said Lt. Gen. Dr Naresh Parmar, CEO – Apollo Hospitals, Karnataka Region.Apollo Hospital, Sheshadripuram, would focus on five specialties Cardiac Sciences, Neurosciences, Orthopaedics, Medical & Surgical Gastroenterology & General and Laparoscopic Surgery led by a team of experts with combined experience of over 100 years.Apollo Hospitals Launched A Super Specialty Hospital At Sheshadripuram In Bangalore

Hyderabad, September 23rd, 2021 : A team of Cardiologists led by Dr Karunakar Rapolu, Consultant Cardiologist, Apollo Hospitals; performed a complex interventional procedure using Impella, IVL and OCT; on an extremely critical 61 year old patient. The patient had 90% blockage due to high calcium deposit in the Left Main Vessel, which was jeopardising the blood supply to already severely weakened heart. A preliminary medical evaluation found him unsuitable for a bypass surgery, due to his past history of Coronary Artery Disease and having undergone an angioplasty three years ago. The Team had to swiftly explore for options to restore blood circulation before his condition deteriorated further and became fatal. The patient Mr Ravinder Reddy, a retired police official, presented with excruciating chest pain and symptoms of severely restricted blood flow to the heart due to calcification of the largest coronary artery, the Left Anterior Descending Artery (LAD). The LAD became narrow progressively since his previous angioplasty and manifested in the form of a massive heart attack. At the Hospital the patient was quickly wheeled into the Cath lab for an angiogram to assess the extent of heart damage. However, he developed dysfunction of the Left ventricular heart chamber, on the table, leading to sparse supply of blood to the vital organs and potential damage of those if not acted instantaneously. This episode further complicated his condition and the team had to resort to administering diuretics to rid excess fluids from the patient’s body and vasodilators to open the blocked vessels.His perilous condition ruled out any scope of performing the risk laden bypass surgery. The team narrowed down on the most apt option considering his delicate condition, of performing a CHIP Intervention (Complex High-risk Indicated Procedure) along with an Impella Heart Pump. CHIP Intervention is a highly critical procedure performed for immediate restoring of blood supply in the circulation system, while Impella replicates the work done by Left Ventricle, helps suck the oxygenated blood from the Left Ventricle and pumps it to the circulatory system. Using the infrared light guidance from OCT (Optical Coherence Tomography), the extent of occlusion was assessed and those high resolution images facilitated clearing of the blockage with precision. Intravascular lithotripsy (IVL) Balloon was used to crack the impregnable calcification of the blockage. IVL deploys acoustic pressure waves to break the calcium deposits. A stenting was done of the Left Main Coronary Artery using DK crush technique for the best outcome.During the course of the procedure the patient suffered 7-8 episodes of “Ventriculo arterial uncoupling” while inflating the balloon to clear occlusion, where the left ventricle ceased pumping the blood. Impella got into action and ensured uninterrupted supply of blood. The patient would have crashed during the procedure if Impella was not availed. The procedure took four and half hours, patient was moved out of ICU after 24 hours of the procedure. He has since recovered and was discharged on the 4th day of admission. He needs to take regular medicines and to follow healthy life style habits like regular exercises and diet management. Patient tolerated the procedure very well because of Impella heart pump which was working continuously to protect him, Oct guided the team to be precise, while IVL helped in the success of the procedure, says Dr Karunakar Rapolu.About Apollo Hospitals:It was in 1983, that Dr. Prathap C Reddy made a pioneering endeavour by launching India’s first corporate hospital – Apollo Hospitals in Chennai.Now, as Asia’s foremost trusted integrated healthcare group, its presence includes over 12,000 beds across 72 Hospitals and 4100 pharmacies, over 120 Primary Care clinics and 650 Diagnostic centres, 700 plus Teleclinics, over 15 medical education centres and a Research Foundation with a focus on global Clinical Trials. The most recent investment being the commissioning of South East Asia’s very first Proton Therapy Centre in Chennai.Every four days, the Apollo Hospitals Group touches a million lives, in its mission to bring healthcare of international standards within the reach of every individual. In a rare honour, the Government of India had issued a commemorative stamp in recognition of Apollo’s contribution, the first for a healthcare organization. Apollo Hospitals Chairman, Dr. Prathap C Reddy, was conferred with the prestigious Padma Vibhushan in 2010.For 37 years, the Apollo Hospitals Group has continuously excelled and maintained leadership in medical innovation, world-class clinical services and cutting-edge technology. Its hospitals are consistently ranked amongst the best hospitals in the country for advanced medical services.

 Actor Sai Dharam Tej’s Health Bulletin Updates14 Sept, 2021Mr. Sai Dharma Tej is stable and is in the weaning mode of respiratory support. The vital parameters and the biomedical tests are satisfactory. The expert team of Doctors will continue to observe his clinical condition further.13 Sept, 2021Mr. Sai Dharma Tej condition is stable. He is on the weaning mode of ventilation and showing a good progress . The vital parameters and the biomedical tests are satisfactory.12 Sept, 2021Mr. Sai Dharma Tej condition is stable and improving . The procedure for collar bone fracture has successfully been completed by our multidisciplinary team of experts.He will continue to be under observation11th Sept, 2021Mr. Sai Dharam Tej was brought to Apollo Hospitals, Jubilee Hill, following a road traffic accidentHe was intubated and put on assisted respiration at the nearest hospital and later shifted here. As of now he is medically stable. There are no major injuries to brain, spine and major organs, based on preliminary investigations. He sustained soft tissue injuries and a collar bone fracture.He is being closely monitored and further evaluation will be bone, over the next 24 hours. There is no need for any immediate surgical intervention.The next medical update will be released at 9am tomorrow morning11th Sept, 2021Mr. Sai Dharam Tej is stable and all major organs are functioning well.He will continue to be on assisted respiration in ICU for controlled close monitoring and additional investigations will be performed during the day.

Apollo Proton Cancer Centre (APCC) is poised to revolutionize global healthcare. In collaboration with Belgium-based IBA, a global leader in proton therapy, APCC, in its series of training programs on PBT, recently completed imparting training to its first batch of eminent doctors from Indonesia and Vietnam. Through this initiative, India becomes the first country in Southeast Asia to host a specialized proton beam therapy training program for international oncologists.Being the first Indian cancer centre to launch the training program in PBT, it marks a new chapter in collaborative cancer treatment and solidifies its position as a front-runner in knowledge sharing and advancing global cancer care. Similar training programs are in the pipeline for oncologists from Kazakhstan, Malaysia, Slovenia and Philippines.Advantages of PBT training at APCCOver 1400 patients have been successfully treated. Patients from over 147 countries access Apollo Hospitals. Practicum-an intensive clinical and academic event with experts in PBT from six continents. Over 350 National and International Virtual tumor board discussions Successful implementation of organ based practice for all modalities Pro Connect–a platform for our clinical network with international oncologists to discuss advanced and complicated cancers.Proton Beam Therapy has emerged as a highly precise and effective radiation treatment for various cancers, offering targeted tumor treatment while minimizing damage to surrounding healthy tissues. So far, APCC has treated over 1400 patients, the youngest being a 10-month-old boy, and has achieved remarkable clinical outcomes, elevating the quality of life of cancer warriors.H. E. Mr. Didier Vanderhasselt, Ambassador of Belgium to India, honored the event as a chief guest, and said, “From the historic beginnings of diplomatic relations between Belgium and India to the present day, where pioneering advancements in healthcare stand testament to our enduring collaboration. Belgium is proud to support initiatives that drive innovation and excellence in cancer care.“In a powerful statement marking the occasion, Dr. Preetha Reddy, Executive Vice Chairperson of Apollo Hospitals Enterprises Limited, emphasized the transformative impact of their collaboration with IBA. “This alliance is a testament to our dedication to forging global healthcare partnerships. By uniting our strengths and expertise, we significantly enhance our collective capacity to tackle cancer worldwide. The training program is a landmark event in our partnership, facilitating an unhindered exchange of knowledge across frontiers. It equips Oncologists globally with cutting-edge insights into Proton Beam Therapy. This collaboration is a clear manifestation of our unified vision to democratize access to innovative treatments worldwide, heralding a new era in healthcare where advanced solutions are within reach for everyone.”Dr. Nguyen Thi Minh Hue, Radiation Oncologist, Cho Ray Hospital, Vietnam, said, “Participating in the specialized training program at Apollo Proton Cancer Centre is an exceptional opportunity to enhance our skills and knowledge in Proton Beam Therapy. We look forward to acquiring valuable skills and knowledge during the training program which will enable us to better serve our patients and contribute to the development of cancer care in Vietnam.”Dr. Febryono Basuki Raharjo, HOD-Radiation Oncology, Dharmais National Cancer Center, Indonesia, said, “Being part of the proton beam therapy training initiative at APCC is a game-changer for Indonesian oncologists. India stands as a beacon of world-class expertise in cancer care, and the Centre exemplifies this commitment to excellence. Through this training, we aim to bring the benefits of PBT to more patients in Indonesia and beyond, ultimately improving cancer care outcomes in our region.”The event was further graced by the below dignitaries Mr Dadang Hidayat, Minister Counsellor, Embassy of the Republic of Indonesia, New Delhi, Mr. Basir Ahmed, Deputy Chief of Mission, from the Indian Ambassador in Indonesia, and Mr. N Ashok Kumar, Adviser, (Industry & Engineering), Embassy of India to Belgium who joined virtually.The training program at APCC is meticulously designed to enhance the skills and knowledge of oncologists from diverse backgrounds, fostering collaboration and knowledge exchange to drive further innovation in cancer treatment. Through this initiative, APCC and IBA aim to empower doctors with the expertise necessary to deliver superior cancer care to patients across the region.

 Hyderabad, July 2021: The three day ‘TCT India South Asia 2021′ – India’s premier Interventional Cardiology Conference – organized by FACTS Foundation – a non-profit organization of Cardiologists and Cardiac Surgeons, committed to newer research, innovation, education, and training; in association with Apollo Hospitals and Cardiovascular Research Foundation, will be hosted virtually from July 29th, 2021. Mr Y Subramanyam, Regional CEO, Apollo Hospitals, Hyderabad; Dr A. Sreenivas Kumar, Founder Director, FACTS Foundation; & Sr. Consultant Cardiologist & Director Cardiology and Clinical Research, Apollo Hospitals, Hyderabad; Dr Ravindra Babu, Asst. Director of Medical Sciences, Apollo Hospitals, and Dr Rama Krishna, Cardiologist, Apollo Hospitals; announced the details of the Virtual conference at a press conference, today at Apollo Hospitals. This event is being successfully conducted for the 12th year now in 2021, the maiden Conference was held in 2010.Dr A. Sreenivas Kumar speaking on the occasion said, this is now the largest Conference of Interventional Cardiologists, with delegates from India, Bangladesh, Nepal, Myanmar, Mauritius, Sri Lanka, and more countries are attending it. Several special techniques to deal with cardiac problems which hitherto needed cardiac surgery can be done today by interventional cardiology, through the minor aperture, saving the patient from trauma, morbidity, and mortality. In the past when arteries were totally blocked, surgery was mandatory, now there are special techniques to clear the blocked arteries, several such new techniques will be demonstrated and deliberated in this conference. It’s difficult to get so much knowledge from the most eminent specialists, this platform brings all of them together and makes the knowledge available in a nutshell to the delegates. The live streaming of the Conference is happening at all the PVR cinemas across the country, the big screens help delegates to get a clear picture of the procedures and techniques and enable a better understanding of what is being demonstrated. This conference has special sessions devoted to Covid Cardiology addressed by eminent specialists from across the world, who extensively dealt with Covid related cardiology problems. The conference overall will address and educate the delegates on the latest techniques beneficial to the patients in terms of speedy recovery and being inexpensive to the possible extent.Mr Y Subramanyam said, more than 5000 delegates registered for this conference making it one of the biggest Interventional Cardiology Conferences. Cardiologists from across the globe are immensely excited about the knowledge in store this Conference is going to impart.The faculty at the Conference comprises the world’s eminent Interventional Cardiologists and several leading Indian cardiologists. The International faculty of World-Renowned Interventional Cardiologists includes Dr Martin B. Leon, Director, New York-Presbyterian Hospital; Dr Gregg W. Stone, Director, New York-Presbyterian Hospital; Dr Dimitrios Karmpaliotis, Interventional Cardiology Specialist, New York, NY; Dr. Gary Mintz, Senior Medical Advisor, Cardiovascular Research Foundation, New York; Dr Susheel Kodali, Director, New York-Presbyterian Hospital; Dr Ajay J. Kirtane, Director, New York-Presbyterian Hospital; Dr Ziad A. Ali, cardiologist, New York; Dr Duane Pinto, Interventional Cardiology, Harvard Medical School; Dr Sanjog Kalra, Interventional Cardiologist, Columbia University Medical Center Education, New York; Dr Miroslaw Ferenc, University Heart Center Freiburg – Germany and Dr Ramesh Daggubati, Director Structural Heart Interventions, West Virginia University, WV, among others.The Conference will have 24 Live cases to be streamed live to 4K projections across 9 Hubs, a first-of-its-kind initiative in India, thereby multiplying the reach of the knowledge being imparted. Over 5000 delegates from across the country and abroad are expected to participate, making it one of the largest Interventional Cardiology conferences. The latest techniques used in performing complicated procedures will be telecast live from leading cardiac centers abroad and across India. The eminent faculty will have the comfort to demonstrate the techniques from the Cath labs they function from, enabling them to be at their proficient best from familiar environs. Live Cases will be transmitted from the USA, Germany & UK and 20 Centers across India, some of the centers participating in the live transmission are Apollo Health City, Hyderabad; Apollo Hospitals, Chennai; Apollo Hospitals, Bengaluru; Apollo Hospitals, Mumbai; Medanta, New Delhi, etc.The Conference will deliberate and demonstrate the latest advances in interventional cardiology, including Transcatheter aortic valve replacement (TAVR), Railway Catheter & other newer Radial Access Devices & techniques, LAA Occlusion Procedures, Pharmacology for Interventionists, Antiplatelet therapy, How FFR and IVUS/OCT optimize patient outcomes, Mitra Clip, Transseptal Technique; etc., through live workshops and also throw light on topics like Role of Telemedicine & AI in tough Covid times, “India has got Talent Sessions” – Young & Dynamic Interventional Cardiologists across India and Asia can showcase their talent.EDUCATION WITH LIVE CASES IN ENTERTAINMENT SPACES (EDUTAINMENT) in TOUGH COVID TIMES….....

More than 250 school children, teachers and gym instructors received training in Basic Life Support and First-Aid today at Apollo Institute of Medical Sciences and Research (AIMSR), Hyderabad. The training in Cardio-Pulmonary Resuscitation (CPR) was done by a team of Life-Support Instructors from Department of Emergency Medicine, Apollo Hyderabad, as a part of the National Assembly on Pediatric Emergency Medicine (NAPEM) conference. NAPEM 2017 is being conducted by the Society for Trauma and Emergency Pediatrics (STEP) in collaboration with the Society for Emergency Medicine India (SEMI), the Indian Academy of Pediatrics (IAP) and Apollo Hospitals. The conference is hosted with the intent of raising the awareness and standard of care for pediatric emergencies in all hospitals.Dr. Imron Subhan, Head of the Apollo Hyderabad Emergency Department, said “In an emergency, bystanders who witness an accident should provide first-aid and quickly get the victim to the hospital. If they hesitate or delay the transportation, then even emergency doctors cannot do much for a patient. Every family should have at least one person trained in Basic Life Support and First-Aid skills”. Dr. Dinakar who was the lead instructor said “CPR and First- Aid training should be a part of the every school curriculum along with other subjects like History, Geography and Science”.More advanced training in pediatric emergency care was conducted in the state-of-art Simulation Training Center at Apollo, where more than 160 emergency doctors and pediatric specialists practised management of medical emergencies and trauma situations on simulated robotic manikins.Dr. Imron, who is also the organizing secretary for the conference said “We have to make all emergency departments safer for children, and better take care of sick and injured pediatric patients. Children with emergency conditions are bound to land up both, in pediatric, as well as adult emergency departments. All emergency doctors have to be ready to resuscitate and stabilize infants and children, and this can happen only with good training by using simulated scenarios on manikins.Faculty for this training included both National and International experts in pediatric emergency medicine, and from the Society for Trauma & Emergency Pediatrics, and the Society for Emergency Medicine India.Call Us Now 08069991035   

Hyderabad, July 2021: A team of doctors led by renowned Cardiothoracic Surgeon and Padmasri awardee Dr. Alla Gopala Krishna Gokhale performed a rare, combined Heart and Lung transplant on 20th July 2021 to save a terminally ill twenty-five-year-old woman, Ms Labdhi Jain. The recipient was unfortunately born with congenital heart disease with a hole in her heart known as a ventricular septal defect and an abnormal connection between her great arteries (Aorto-pulmonary window). Over the years, the congenital defect led to further deterioration in her health condition with increased lung pressures and leakage of heart valves. She was surviving on oxygen support at home for the last two-and-half years. Of late, she was admitted at various hospitals several times for heart failure. The transplant team at Apollo Hospitals, Hyderabad, on evaluation found her to be in an advanced stage of heart failure coupled with increased lung pressures. The team prescribed combined Heart and Lung transplantation to save her life. She was registered under the State Government’s Jeevandan Cadaver Transplantation program and was waiting for a suitable donor. The team faced unique challenges in this case. The recipient at the time of listing for transplant weighed only 30 kgs. Getting a suitable organ which was of appropriate in size for her was complex, as her heart cavity was small. She was helplessly waiting for a suitable organ for a prolonged period of over two and half years, with the hope of finding a small-sized organ diminishing by the day.The cadaver heart and lung obtained from an eighteen-year-old girl, pronounced brain dead due to intracranial bleeding and thrombosis, aptly suited her requirement. Despite the immense sorrow of losing their child, the donor’s family displayed exemplary courage and benevolence and gave consent to harvest their braindead daughter’s organs. This humanitarian gesture on behalf of the grief-stricken loved ones brought joy back in the life of another family.The recipient recovered well after surgery; her weight has improved to 38 kgs. She is being discharged from the hospital, freed from the burden of heart and lung disease, to enjoy life the way she deserves, and to overcome any obstacles that come her way with confident strides and a happy heart.About Apollo HospitalsIt was in 1983, that Dr. Prathap C Reddy made a pioneering endeavor by launching India’s first corporate hospital – Apollo Hospitals in Chennai. Now, as Asia’s foremost trusted integrated healthcare group, its presence includes over 12,000 beds across 72 Hospitals, 3800 pharmacies, over 120 Primary Care clinics, and 650 Diagnostic centers, 700 plus Teleclinics, over 15 medical education centers, and a Research Foundation with a focus on global Clinical Trials. The most recent investment is the commissioning of Southeast Asia’s very first Proton Therapy Centre in Chennai.Every four days, the Apollo Hospitals Group touches a million lives, in its mission to bring healthcare of international standards within the reach of every individual. In a rare honor, the Government of India had issued a commemorative stamp in recognition of Apollo’s contribution, the first for a healthcare organization. Apollo Hospitals Chairman, Dr. Prathap C Reddy, was conferred with the prestigious Padma Vibhushan in 2010. For 38 years, the Apollo Hospitals Group has continuously excelled and maintained leadership in medical innovation, world-class clinical services and cutting-edge technology. Its hospitals are consistently ranked amongst the best hospitals in the country for advanced medical services.

 Hyderabad, July 2021: Apollo Hospitals, hosted a unique and colorful march past to commemorate the National Doctors’ Day. The hospital staff from across departments took part in the march past and greeted the Doctors present on a podium, as they passed by, at Apollo Health City, Jubilee Hills, today.The impressive celebrations were organized as a mark of reverence and to express immense gratitude to the Doctor community for their unparalleled commitment and dedication to patient care in the most trying of circumstances, prevailing due to COVID 19. The march past had all the pomp and gaiety associated with festivities. The security personnel led the march to the melodious and rhythmic tunes of Police band. The other marching contingents comprised of Bike ambulances, Critical care ambulances and staff from different departments, holding placards, banners, applauding the initiative of Doctors.Speaking on the occasion Mr Y Subramanyam, Regional CEO, Apollo Hospitals, Hyderabad; said, only a Doctor is blessed with the magical powers to treat a life, bring health in our lives and be there with us when we have lost all the hopes and that’s the reason Doctors are precious. But for patient’s every day is a Doctors’ day as during their moment of distress and trauma no one else can be their saviour.Dr Ravinder Babu, Medical Superintendent, Apollo Hospitals, Jubilee Hills; said, when the pandemic struck last year, like everyone else the doctors too perceived enormous risk to themselves and their families, but the commitment to the patients is what kept them going. That dedication is what overweighed all other considerations, empowered them to bravely confront the disease despite personal risk and that made a difference to several lives. For every Doctor the prime concern is how to save his patient from distress and for that they go to any extent, even risking their lives.Dr. P. Vijay Anand Reddy, Director, Apollo Cancer Institute, Apollo Hospitals, Hyderabad; said, as a Doctor the love and trust we win from the patients after successfully treating them merits above everything else. All of us in this profession strive for that moment of joy the patient expresses and that gives us the ultimate satisfaction.About Apollo HospitalsIt was in 1983, that Dr. Prathap C Reddy made a pioneering endeavor by launching India’s first corporate hospital – Apollo Hospitals in Chennai. Now, as Asia’s foremost trusted integrated healthcare group, its presence includes over 12,000 beds across 72 Hospitals, 3800 pharmacies, over 120 Primary Care clinics and 650 Diagnostic centers, 700 plus Teleclinics, over 15 medical education centers and a Research Foundation with a focus on global Clinical Trials. The most recent investment being the commissioning of Southeast Asia’s very first Proton Therapy Centre in Chennai.Every four days, the Apollo Hospitals Group touches a million lives, in its mission to bring healthcare of international standards within the reach of every individual. In a rare honor, the Government of India had issued a commemorative stamp in recognition of Apollo’s contribution, the first for a healthcare organization. Apollo Hospitals Chairman, Dr. Prathap C Reddy, was conferred with the prestigious Padma Vibhushan in 2010. For 38 years, the Apollo Hospitals Group has continuously excelled and maintained leadership in medical innovation, world-class clinical services and cutting-edge technology. Its hospitals are consistently ranked amongst the best hospitals in the country for advanced medical services.

A seven year old boy with rare ‘Wilson’s Disease’ and fighting for life, was transplanted with liver at Apollo Hospitals!Hyderabad, February, 2017: Transplant Team at Apollo Hospitals performed liver transplant on a kid fighting for his life due to a genetic disorder – Wilson’s Disease and acute Liver failure, needing immediate medical intervention. The surgery was performed against all odds, using a slice from his mother’s liver.  Seven year old, Master T. Siddhartha Reddy, from Jeedimetla, was fighting for his life when he was first seen by Pediatric Hepatologist at Apollo Hospitals, Jubilee Hills, Dr Ramesh Srinivasan. Investigations revealed that he was suffering from a rare ailment called Wilson’s disease and Acute Liver Failure. Wilson’s disease is a genetic disorder in which copper builds up abnormally in the liver, eyes and brain. This overload of copper in the liver results in Liver failure. Often an otherwise apparently normal child can suffer with life threatening acute liver failure in this setting, warranting urgent liver transplantation, says Dr Ramesh Srinivasan. Majority of the people with the Wilson’s gene will be carriers of the gene and will not manifest the disease.It all began in the last week of December when Siddhartha Reddy was found to have jaundice. A spell on fever on the New Year day made his condition worse and the already diseased liver gave up entirely. His blood clotting parameters became abnormal and the INR – a measure of the blood’s ability to form clots; climbed up to 6.7, the normal value should be 1. When the liver is diseased this value increases and such patients are at a very high risk of bleeding at multiple sites in the body, including the brain. The alarming parameters prompted Dr Srinivasan to involve the liver transplant team at Apollo Hospitals, Jubilee Hills, Hyderabad.“When we saw the patient, he had very high bilirubin levels and his clotting parameters were so abnormal, we had to give him Fresh Frozen Plasma to keep his INR in the safe limit”, says Dr Manish Varma, Chief Liver Transplant Surgeon at Apollo Hospitals, Jubilee Hills.Siddhartha was immediately listed in the super-urgent category with Jeevandan. However, the team of doctors knew that they could not wait indefinitely and the patient was fast running out of time. Thankfully, the boy’s mother, a homemaker, had a matching blood group and the liver was found to be fit for donation. The next challenge to overcome was thelong weekend to follow starting with Sankranti holiday, necessitating completion of all the tests and the medico-legal paperwork within a day. The entire team including the Social work department worked overtime to make this happen and the medical tests for the donor, the legal paperwork were done within the day and the hospital authorization committee was requested to give an expedited clearance for the operation.The liver transplant took place in the early hours on 14th January, 2017 and was performed by a team led by Dr Manish C. Varma. However, for the transplant team challenges were far from over. The part of the liver that the mother donated, came with two very small blood vessels. The size of the vessels was 1 mm and 1.5 mm. “It is technically very challenging to join blood vessels that are small and the chances of they clotting again in the post-operative period was also very high, explained Dr. Manish Varma. Further the boy had to be given blood thinning medicines immediately after the transplant, which increases the risk of post-operative bleeding. How the highly experience Transplant team at Apollo Hospitals, weathering all the challenges and triumphantly completed the surgery. The boy has since recovered and has been discharged. 

Apollo Hospitals, Chennai, organized a scoliosis awareness walkathon at Colombo Independence Square with a primary objective of enlightening the public about making a scoliosis free Sri Lanka.The walk was organized in association with Serendib Group and Lanka E Doc Company. The event witnessed the participation of a multitude of individuals, including prominent figures from various fields. Dr. Niluka Welikala, President of both organizing entities, emphasized the global necessity of creating awareness among parents regarding scoliosis in children, which has a high incidence among adolescent girls in Sri Lanka.Dr. Welikala also highlighted that the dearth of awareness among parents has resulted in a diminished capacity to prevent the progression of the disease in children. Hence, she stressed the crucial role of educating parents about scoliosis. Among the notable participants were Dr. Panwila Ananda Thero, Head of Attanagalla Rajamaha Vihara, and Venerable Thiniyawala Palitha Thero. Justice Minister Vijayadasa Rajapaksa, Minister of State for Transport Lasantha Alagiyawanna, and Dr. Sajan K Hegde, Chief Spine Surgeon, Apollo Hospitals, Dr Appaji Krishan Senior Spine Surgeon Apollo Hospitals and Dr Ruwanthi Perara, Senior Consultant Paediatrician, along with other Indian and Sri Lankan specialist doctors.Dr. Niluka Welikala expressed gratitude for the support extended by Apollo Hospitals Group for the program and stated that the walkathon, with nearly 1,000 participants, should be the world’s largest scoliosis awareness walkathon. Mr Jithu Jose, Vice President, International Division of Apollo Hospitals, proposed the vote of thanks. The event served as a significant step forward in the collective effort to combat scoliosis and ensure a healthier future for the people of Sri Lanka.

‘Apollo Cancer Conclave’ throws light on new innovations that will immensely benefit the patients & aid physicians to effectively treat cancersHyderabad, February 8th, 2017 : The 3rd edition of APOLLO CANCER CONCLAVE & 7th edition of their biennial CANCER CI – 2017 conducted from 2nd to 5th February 2017, at HICC, Hyderabad, was a resounding success, with a record 2340 delegates attending it. Globally acclaimed faculty comprising of Basic research Scientists, site specific Cancer experts, presented their data, participated in patient specific case discussions, issue based discussions and highlighted several recent innovations.  The advent of these new innovations will immensely benefit the patients and aid treating physicians to effectively combat cancer.Robotic SurgeryNewer techniques of Robotic Surgery which can be used for newer areas and with more ease, were presented.TOMOTHERAPY & Proton therapyAdvanced Radiation techniques, Tomotherapy & Proton therapy will drastically bring down the treatment duration and will replace Surgery in several areas of Cancer treatment. Also the whole body Radiation, whole marrow Radiation, multiple site treatment can be done in one go, making treatment less traumatic.Liquid BiopsyThe hallmark of modern era cancer care is ‘Tailored therapy’ as it has been identified that ‘every patient is different.’ This tailored therapy relies on the determination of molecular targets on the tumour.Liquid biopsies are non-invasive blood tests that detect circulating tumour cells and cell free tumor DNA, that are shed from the tumour and thus compliment an invasive biopsy.Liquid biopsy can be used to identify these targets and modify treatments, apart from their primary role in diagnosis. It also helps in identifying sensitivity of tumour to various chemotherapeutic agents. Liquid biopsy can also be used to predict the toxicity of a particular therapeutic agent by pharmacogenetic analysis.Pharmacogenomic ProfilingMost cancer drugs are effective in only a fraction of patients who take them. Identification of this responsive subset of patients would spare useless cytotoxic treatment. This sensitivity is identified by pharmacogenomics profiling. This can be done on tumor tissue or on Liquid biopsy.Genetic Tests in disease & screeningGene mutations that lead to cancer may be inherited from a parent or may happen spontaneously during a person’s lifetime. Genetic testing is the process of using medical tests to look for these changes in a person’s genes lost chromosomes. Genetic testing is used to see if a person has certain gene mutates known to increase the rest for a certain cancer eg. BRCA mutation testing in Breast Cancer.Immunotherapy, also called biologic therapy is a type of Cancer treatment designed to boost the body’s natural defenses to fight cancer. It uses substances either made by the body or in a laboratory to improve or restore immune system function.Checkpoint Inhibitors (CPI) block normal proteins on cancer cells, or the proteins on the T-Cells that respond to them. CPI seek to overcome one of Cancer main defenses against an immune system attack.Cancers which can be treated with Immunotherapy areMelanoma – Nivolumab and Pembrolizumab.Hodgkin’s Lymphoma – NivolumabHead & Neck Cancers – NivolumabLung Cancers – Nivolumab & PembrolizumabLung – New way of treating Cancer…Immune checkpoints affect immune system functioning. Immune checkpoints can be stimulatory or inhibitory. Tumors can use these checkpoints to protect themselves from immune system attacks. Checkpoint therapy can block inhibitory checkpoints, restoring immune system function.For example –One such ligand-receptor interaction under investigation is the interaction between the transmembrane programmed cell depth 1 protein (PDCD1, PD-1; also known as CD279) and its ligand, PD-1 ligand 1 (PD-L1, CD274).Many cancer cells express PD1-L1 protein on their surface so that the immune system recognizes this marker as our own cell that should not be killed. Our immune T cell have another protein that is called PD1 or check point protein that involved in the recognition of PD1-L1. When PD1 marker on the immune T cell interacts with PD1-L1 marker on cancer cell the T cell dies or gets inactivated. This way cancer kills our T cells of our immune system and gets stronger whereas our immune system gets weaker. The immunotherapy drugs block the PD1 check point on T cells so that they cannot interact with PD1-L1 on cancer cells and cannot get killed or inactivated. With the blocked check point (PD1) the T cells kill cancer cells without a problem. In summary PD1 is sitting on our T cells and PD1-L1 is sitting on cancer cells. And there is a battle between them. Either cancer cells kills T cell or T cell kills cancer cell.Nivolumab, Pembrolizumab are the new approved drugs for usage in Lung cancer.The immunotherapy drugs are known to be better than Chemotherapy in terms of response and survival.Neuro OncologyHippocampal sparing while treating brain tumors will improve the QOL – Neurocognitive function and memory.Immunotherapy in Brain MetastasesTreatment of brain metastases remains a challenge as most therapeutic agents do not cross the blood brain / barriers. Immunotherapy involves the activation of the immune system in T cells that cross the barrier. Recent studies have shown the efficiency of Pembrolizumab in treatment of Brain metastases in patients with melanoma and Lung Cancers.Head & Neck CancersHPV virus induced Cancers are increasing in our country too. These tumors are mostly in the Oropharynx and throat and are highly curable with less intensive treatment. Immunotherapy in H&N cancers.